Stay updated on Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T16:29:35.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-02T14:23:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8. Additionally, a section on HHS Vulnerability Disclosure has been added.
    Difference
    0.2%
    Check dated 2025-07-26T12:21:48.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-19T11:05:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.
    Difference
    0.8%
    Check dated 2025-07-12T07:28:10.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.9%
    Check dated 2025-07-05T02:36:22.000Z thumbnail image

Stay in the know with updates to Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.